THERAKOS CELLEX SYSTEM
Report
- Report Number
- 2523595-2014-00069
- Event Type
- Malfunction
- Date Received
- March 5, 2014
- Date of Event
- February 7, 2014
- Report Date
- February 7, 2014
- Manufacturer
- THERAKOS, INC.
- Product Code
- LNR
- PMA / PMN Number
- P680003
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- NURSE
Narratives
BATCH RECORD REVIEW OF LOT B125 WAS CONDUCTED. THERE WERE NO NON CONFORMANCES RELATED TO THIS TYPE OF FAILURE FOR THIS LOT. LOT MET RELEASE REQUIREMENTS. TRENDS HAVE BEEN REVIEWED ON A LOT BY LOT BASIS FOR THIS COMPLAINT CATEGORY AND NO TREND HAS BEEN DETECTED FOR THIS SPECIFIC LOT. THE ASSESSMENT IS BASED ON INFORMATION AVAILABLE AT THE TIME OF THE INVESTIGATION. PRODUCT WAS NOT RETURNED BY CUSTOMER FOR INVESTIGATION, BUT A PHOTO EVALUATION IS STILL IN PROGRESS; THEREFORE, NO ROOT CAUSE COULD BE DETERMINED AT THIS TIME AS EVALUATION IS STILL IN PROGRESS. (B)(4).
CUSTOMER CALLED TO REPORT A TUBING LEAK THAT OCCURRED DURING TREATMENT. NAME AND FUNCTION OF COMPLAINANT: SAME AS REPORTER. CUSTOMER CALLED TO REPORT THAT DURING THE TREATMENT THE TUBING SEGMENT INSTALLED IN THE RECIRCULATION PUMP HAS BEEN TORN OFF THE PUMP TUBING ORGANIZER. CUSTOMER STATED THAT THE INCIDENT OCCURRED AT 1036 ML WHOLE BLOOD PROCESSED. PRIME FLUID DID NOT EXIT THE KIT, BUT NO BLOOD SPILLED OVER THE PUMP DECK. NO ALARM DID OCCUR DURING THE LEAK. NO ALARM OR VISIBLE LEAK OCCURRED DURING PRIME AND DURING THE TREATMENT BEFORE THE INCIDENT OCCURRED. OPERATORS PERFORMED ALL THE USUAL CONTROLS DURING KIT INSTALLATION TREATMENT WAS ABORTED AND PATIENT IS STABLE. CUSTOMER THREW KIT AWAY, SO NO INVESTIGATION WILL BE PERFORMED ON THE KIT USED. CUSTOMER PROVIDED ONE PICTURE FOR EVALUATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 131523 | THERAKOS CELLEX SYSTEM | CELLEX | LNR | THERAKOS, INC. | B125 KIT |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 23 YR |